Lumisys acquires X-Ray Scanner Corp.
Lumisys has bolstered its position in the x-ray film digitizermarket by acquiring X-Ray Scanner Corp. The deal was completedMarch 13 and Lumisys has begun integrating XRS into its company,according to John Burgess, vice president of sales and
Lumisys has bolstered its position in the x-ray film digitizermarket by acquiring X-Ray Scanner Corp. The deal was completedMarch 13 and Lumisys has begun integrating XRS into its company,according to John Burgess, vice president of sales and marketingfor Lumisys, of Sunnyvale, CA.
Lumisys is the only player in the high-end laser film digitizermarket in the U.S., but for several years has wanted to add lowerpriced CCD-based digitizers to its product line. A proposed mergerin 1993 with CCD digitizer manufacturer Vision Ten fell throughdue to litigation Vision Ten was involved in (SCAN 4/7/93 and1/27/93).
XRS has six CCD digitizer products and a 20% share of the CCDdigitizer market. Lumisys will move the Torrance, CA, office ofXRS to Sunnyvale this summer, Burgess said. The office has about12 employees and produced annual sales of about $1 million. Annualsales of Lumisys are about $12 million, according to Burgess.
Lumisys believed it needed to broaden its digitizer line tocover lower price points and preferred to do so through acquisitionrather than developing new products in-house, Burgess said.
"There was a real opportunity to expand our product lineand take advantage of some of the developments they've made,"Burgess told SCAN. "We will now cover the entire range ofscanner capabilities and prices."
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
